Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children.

Sherief LM, Kamal AG, Khalek EA, Kamal NM, Soliman AA, Esh AM.

Hematology. 2012 May;17(3):151-6. doi: 10.1179/102453312X13376952196412.

PMID:
22664114
[PubMed - indexed for MEDLINE]
2.

Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.

Mavinkurve-Groothuis AM, Marcus KA, Pourier M, Loonen J, Feuth T, Hoogerbrugge PM, de Korte CL, Kapusta L.

Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):562-9. doi: 10.1093/ehjci/jes217. Epub 2012 Oct 29.

PMID:
23109647
[PubMed - indexed for MEDLINE]
3.

Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.

Mavinkurve-Groothuis AM, Groot-Loonen J, Bellersen L, Pourier MS, Feuth T, Bökkerink JP, Hoogerbrugge PM, Kapusta L.

Pediatr Blood Cancer. 2009 May;52(5):631-6. doi: 10.1002/pbc.21913.

PMID:
19127569
[PubMed - indexed for MEDLINE]
4.

Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.

Pongprot Y, Sittiwangkul R, Charoenkwan P, Silvilairat S.

J Pediatr Hematol Oncol. 2012 Nov;34(8):589-95. doi: 10.1097/MPH.0b013e31826faf44.

PMID:
23018571
[PubMed - indexed for MEDLINE]
5.

Long-term cardiac effects of treatment for childhood leukemia.

Urbanova D, Urban L, Simkova I, Danova K, Mikuskova E, Mladosievicova B.

Neoplasma. 2010;57(2):179-83.

PMID:
20099983
[PubMed - indexed for MEDLINE]
6.

Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.

Dodos F, Halbsguth T, Erdmann E, Hoppe UC.

Clin Res Cardiol. 2008 May;97(5):318-26. doi: 10.1007/s00392-007-0633-6. Epub 2008 Jan 14.

PMID:
18193371
[PubMed - indexed for MEDLINE]
7.

Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines.

Mladosievicova B, Urbanova D, Radvanska E, Slavkovsky P, Simkova I.

J Exp Clin Cancer Res. 2012 Oct 11;31:86. doi: 10.1186/1756-9966-31-86.

PMID:
23057994
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.

Mavinkurve-Groothuis AM, Kapusta L, Nir A, Groot-Loonen J.

Pediatr Hematol Oncol. 2008 Sep;25(7):655-64. doi: 10.1080/08880010802244001. Review.

PMID:
18850478
[PubMed - indexed for MEDLINE]
9.

N-terminal-proB-type natriuretic peptide as a marker for acute anthracycline cardiotoxicity in children.

Ekstein S, Nir A, Rein AJ, Perles Z, Bar-Oz B, Salpeter L, Algur N, Weintraub M.

J Pediatr Hematol Oncol. 2007 Jul;29(7):440-4.

PMID:
17609620
[PubMed - indexed for MEDLINE]
10.

Assessment of anthracycline-induced cardiotoxicity with biochemical markers.

Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J.

Exp Oncol. 2007 Dec;29(4):309-13.

PMID:
18199989
[PubMed - indexed for MEDLINE]
11.

Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.

Ruggiero A, De Rosa G, Rizzo D, Leo A, Maurizi P, De Nisco A, Vendittelli F, Zuppi C, Mordente A, Riccardi R.

Int J Clin Oncol. 2013 Oct;18(5):927-33. doi: 10.1007/s10147-012-0458-9. Epub 2012 Aug 22.

PMID:
22911020
[PubMed - indexed for MEDLINE]
12.
13.

Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.

Lipshultz SE, Miller TL, Scully RE, Lipsitz SR, Rifai N, Silverman LB, Colan SD, Neuberg DS, Dahlberg SE, Henkel JM, Asselin BL, Athale UH, Clavell LA, Laverdière C, Michon B, Schorin MA, Sallan SE.

J Clin Oncol. 2012 Apr 1;30(10):1042-9. doi: 10.1200/JCO.2010.30.3404. Epub 2012 Feb 27.

PMID:
22370326
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.

Horácek JM, Pudil R, Tichý M, Jebavý L, Strasová A, Praus R, Zák P, Malý J.

Neoplasma. 2005;52(5):430-4.

PMID:
16151589
[PubMed - indexed for MEDLINE]
15.

Brain natriuretic peptide as a cardiotoxicity biomarker in children with hematological malignancies.

Tragiannidis A, Dokos C, Tsotoulidou V, Giannopoulos A, Pana ZD, Papageorgiou T, Karamouzis M, Athanassiadou F.

Minerva Pediatr. 2012 Jun;64(3):307-12.

PMID:
22555323
[PubMed - indexed for MEDLINE]
16.

Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus.

Salem M, El Behery S, Adly A, Khalil D, El Hadidi E.

Pediatr Diabetes. 2009 Dec;10(8):513-21. doi: 10.1111/j.1399-5448.2009.00517.x. Epub 2009 Aug 25.

PMID:
19708908
[PubMed - indexed for MEDLINE]
17.

Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome.

Ikonomidis I, Nikolaou M, Dimopoulou I, Paraskevaidis I, Lekakis J, Mavrou I, Tzanela M, Kopterides P, Tsangaris I, Armaganidis A, Kremastinos DT.

Shock. 2010 Feb;33(2):141-8. doi: 10.1097/SHK.0b013e3181ad31f8.

PMID:
19487972
[PubMed - indexed for MEDLINE]
18.

Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines.

Germanakis I, Kalmanti M, Parthenakis F, Nikitovic D, Stiakaki E, Patrianakos A, Vardas PE.

Int J Cardiol. 2006 Apr 4;108(2):212-5. Epub 2005 Nov 10.

PMID:
16290101
[PubMed - indexed for MEDLINE]
19.

Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation.

Roziakova L, Bojtarova E, Mistrik M, Dubrava J, Gergel J, Lenkova N, Mladosievicova B.

J Exp Clin Cancer Res. 2012 Feb 9;31:13. doi: 10.1186/1756-9966-31-13.

PMID:
22321767
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.

Steen H, Futterer S, Merten C, Jünger C, Katus HA, Giannitsis E.

J Cardiovasc Magn Reson. 2007;9(5):749-58.

PMID:
17891611
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk